These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 30064395)

  • 21. Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART.
    Ceccherini-Silberstein F; Cozzi Lepri A; Alteri C; Merlini E; Surdo M; Marchetti G; Capobianchi MR; De Luca A; Gianotti N; Viale P; Andreoni M; Antinori A; Perno CF; d'Arminio Monforte A;
    J Antimicrob Chemother; 2018 Dec; 73(12):3460-3470. PubMed ID: 30247724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
    Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP
    Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy.
    Le T; Wright EJ; Smith DM; He W; Catano G; Okulicz JF; Young JA; Clark RA; Richman DD; Little SJ; Ahuja SK
    N Engl J Med; 2013 Jan; 368(3):218-30. PubMed ID: 23323898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of opportunistic illness on HIV RNA viral load and CD4+ T cell count among HIV-positive adults taking antiretroviral therapy.
    Ekwaru JP; Campbell J; Malamba S; Moore DM; Were W; Mermin J
    J Int AIDS Soc; 2013 Apr; 16(1):17355. PubMed ID: 23547778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals.
    Lang S; Mary-Krause M; Simon A; Partisani M; Gilquin J; Cotte L; Boccara F; Costagliola D;
    Clin Infect Dis; 2012 Aug; 55(4):600-7. PubMed ID: 22610928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.
    Palacios R; Senise J; Vaz M; Diaz R; Castelo A
    HIV Med; 2009 Mar; 10(3):157-62. PubMed ID: 19245537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of immune complexes and plasma viral load with CD4+ cell depletion, CD8+ DR+ and CD16+ cell counts in HIV+ hemophilia patients. Implications for the immunopathogenesis of HIV-induced CD4+ lymphocyte depletion.
    Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
    Immunol Lett; 2001 Mar; 76(2):69-78. PubMed ID: 11274723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High Current CD4+ T Cell Count Predicts Suboptimal Adherence to Antiretroviral Therapy.
    Pasternak AO; de Bruin M; Bakker M; Berkhout B; Prins JM
    PLoS One; 2015; 10(10):e0140791. PubMed ID: 26468956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort.
    El-Sadr WM; Mullin CM; Carr A; Gibert C; Rappoport C; Visnegarwala F; Grunfeld C; Raghavan SS
    HIV Med; 2005 Mar; 6(2):114-21. PubMed ID: 15807717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients.
    Santoro MM; Armenia D; Fabeni L; Santoro M; Gori C; Forbici F; Svicher V; Bertoli A; Dori L; Surdo M; Balestra E; Palamara G; Girardi E; Angarano G; Andreoni M; Narciso P; Antinori A; Ceccherini-Silberstein F; Perno CF
    Clin Microbiol Infect; 2012 Aug; 18(8):E289-98. PubMed ID: 22681969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load.
    Phillips AN; Staszewski S; Weber R; Kirk O; Francioli P; Miller V; Vernazza P; Lundgren JD; Ledergerber B; ; ;
    JAMA; 2001 Nov; 286(20):2560-7. PubMed ID: 11722270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can we stop CD4+ testing in patients with HIV-1 RNA suppression on antiretroviral treatment?
    Girard PM; Nelson M; Mohammed P; Hill A; van Delft Y; Moecklinghoff C
    AIDS; 2013 Nov; 27(17):2759-63. PubMed ID: 23842127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activated PD-1+ CD4+ T cells represent a short-lived part of the viral reservoir and predict poor immunologic recovery upon initiation of ART.
    Eller MA; Hong T; Creegan M; Nau ME; Sanders-Buell E; Slike BM; Krebs SJ; Ratto-Kim S; McElrath MJ; Katabira ET; Bolton DL; Michael NL; Robb ML; Tovanabutra S; Baeten JM; Sandberg JK
    AIDS; 2020 Feb; 34(2):197-202. PubMed ID: 31764072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4
    Abadi T; Teklu T; Wondmagegn T; Alem M; Desalegn G
    Eur J Med Res; 2024 Mar; 29(1):178. PubMed ID: 38494500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamics of HIV reservoir decay and naïve CD4 T-cell recovery between immune non-responders and complete responders on long-term antiretroviral treatment.
    Zhang LX; Song JW; Zhang C; Fan X; Huang HH; Xu RN; Liu JY; Zhang JY; Wang LF; Zhou CB; Jin L; Shi M; Wang FS; Jiao YM
    Clin Immunol; 2021 Aug; 229():108773. PubMed ID: 34102315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High level of virological suppression among HIV-infected adults receiving combination antiretroviral therapy in Addis Ababa, Ethiopia.
    Mekuria LA; Nieuwkerk PT; Yalew AW; Sprangers MA; Prins JM
    Antivir Ther; 2016; 21(5):385-96. PubMed ID: 26731316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
    Sterling TR; Chaisson RE; Moore RD
    AIDS; 2001 Nov; 15(17):2251-7. PubMed ID: 11698698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
    Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
    Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized clinical trial of lovastatin in HIV-infected, HAART naïve patients (NCT00721305).
    Montoya CJ; Higuita EA; Estrada S; Gutierrez FJ; Amariles P; Giraldo NA; Jimenez MM; Velasquez CP; Leon AL; Rugeles MT; Jaimes FA
    J Infect; 2012 Dec; 65(6):549-58. PubMed ID: 23085245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.